The Oslo, Norway-based Aker BioMarine Antarctic AS, a customer-driven supplier of krill-derived phospholipid omega-3 products, has received product approval for Superba krill oil from the Food Safety and Standards Authority of India (FSSAI).
According to publicly-available information, Superba krill oil - a natural source of Omega-3 fatty acids such as EPA and DHA, and the antioxidant astaxanthin - is the first and only krill oil that has obtained product approval by the country’s apex food regulator.
“We are delighted to introduce Superba krill oil - an omega-3 product evaluated in several clinical studies - to the Indian market,” said Atul Barman, Aker BioMarine Antarctic AS’ India representative, based in Mumbai.
“This new ingredient approval would enable Indian consumers to benefit from Omega-3 fatty acids in the phospholipid form,” he added.
“Omega-3 phospholipids are more efficiently incorporated into cell membranes, and are therefore an excellent source of Omega-3 fatty acids to support heart, brain and joint health,” Barman informed.
“This approval represents a key milestone for our entry into India,” stated Tim de Haas, vice-president, business development, Aker BioMarine Antarctic AS, Oslo.
He added, “We feel confident that with our local presence, we can successfully support our customers in India.”
“Backed by our success, especially in the United States and Australian markets, expanding into the Indian dietary supplement market presents great opportunities for Superba krill oil,” de Haas added.
According to publicly-available information, Superba krill oil - a natural source of Omega-3 fatty acids such as EPA and DHA, and the antioxidant astaxanthin - is the first and only krill oil that has obtained product approval by the country’s apex food regulator.
“We are delighted to introduce Superba krill oil - an omega-3 product evaluated in several clinical studies - to the Indian market,” said Atul Barman, Aker BioMarine Antarctic AS’ India representative, based in Mumbai.
“This new ingredient approval would enable Indian consumers to benefit from Omega-3 fatty acids in the phospholipid form,” he added.
“Omega-3 phospholipids are more efficiently incorporated into cell membranes, and are therefore an excellent source of Omega-3 fatty acids to support heart, brain and joint health,” Barman informed.
“This approval represents a key milestone for our entry into India,” stated Tim de Haas, vice-president, business development, Aker BioMarine Antarctic AS, Oslo.
He added, “We feel confident that with our local presence, we can successfully support our customers in India.”
“Backed by our success, especially in the United States and Australian markets, expanding into the Indian dietary supplement market presents great opportunities for Superba krill oil,” de Haas added.
No comments:
Post a Comment